18alpha-glycyrrhetinic acid

18alpha-glycyrrhetinic acid is a lipid of Prenol Lipids (PR) class. 18alpha-glycyrrhetinic acid is associated with abnormalities such as Wiskott-Aldrich Syndrome. The involved functions are known as inhibitors, salivary gland development and branching morphogenesis.

Cross Reference

Introduction

To understand associated biological information of 18alpha-glycyrrhetinic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 18alpha-glycyrrhetinic acid?

18alpha-glycyrrhetinic acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 18alpha-glycyrrhetinic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

What functions are associated with 18alpha-glycyrrhetinic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 18alpha-glycyrrhetinic acid

Download all related citations
Per page 10 20 50 100 | Total 209
Authors Title Published Journal PubMed Link
Yu J et al. Disruption of gap junctions reduces biomarkers of decidualization and angiogenesis and increases inflammatory mediators in human endometrial stromal cell cultures. 2011 Mol. Cell. Endocrinol. pmid:21767601
Reuss B et al. Regionally distinct regulation of astroglial neurotransmitter receptors by fibroblast growth factor-2. 2000 Mol. Cell. Neurosci. pmid:10882482
Huang YC et al. 18α-Glycyrrhetinic Acid Induces Apoptosis of HL-60 Human Leukemia Cells through Caspases- and Mitochondria-Dependent Signaling Pathways. 2016 Molecules pmid:27376261
Thust R et al. Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells. 2004 Mutagenesis pmid:14681310
Iqbal Choudhary M et al. Microbial transformation of 18beta-glycyrrhetinic acid by Cunninghamella elegans and Fusarium lini, and lipoxygenase inhibitory activity of transformed products. 2009 Nat. Prod. Res. pmid:19384727
Verwey LJ and Edwards TM Gap junctions and memory: an investigation using a single trial discrimination avoidance task for the neonate chick. 2010 Neurobiol Learn Mem pmid:19796702
Kim DE et al. Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change. 2009 Neurochem. Res. pmid:19224363
Figueroa XF et al. Diffusion of nitric oxide across cell membranes of the vascular wall requires specific connexin-based channels. 2013 Neuropharmacology pmid:23499665
Cavone L et al. 18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis. 2011 Ocul. Immunol. Inflamm. pmid:21426233
Ikarashi Y and Mizoguchi K Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. 2016 Pharmacol. Ther. pmid:27373856